These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7904734)

  • 21. Mortality, neoplasia, and Creutzfeldt-Jakob disease in patients treated with human pituitary growth hormone in the United Kingdom.
    Buchanan CR; Preece MA; Milner RD
    BMJ; 1991 Apr; 302(6780):824-8. PubMed ID: 2025705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serial magnetic resonance imaging changes in sporadic Creutzfeldt-Jakob disease with valine homozygosity at codon 129 of the prion protein gene.
    Furukawa F; Ishibashi S; Sanjo N; Yamashita H; Mizusawa H
    JAMA Neurol; 2014 Sep; 71(9):1186-7. PubMed ID: 25070174
    [No Abstract]   [Full Text] [Related]  

  • 23. Mutation in codon 200 and polymorphism in codon 129 of the prion protein gene in Libyan Jews with Creutzfeldt-Jakob disease.
    Gabizon R; Rosenman H; Meiner Z; Kahana I; Kahana E; Shugart Y; Ott J; Prusiner SB
    Philos Trans R Soc Lond B Biol Sci; 1994 Mar; 343(1306):385-90. PubMed ID: 7913755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Creutzfeldt-Jakob disease with homozygous M232R mutation: A case report.
    Kon T; Miki Y; Arai A; Funamizu Y; Ueno T; Haga R; Nishijima H; Suzuki C; Nunomura J; Baba M; Oyama Y; Shiga Y; Kitamoto T; Tomiyama M
    J Neurol Sci; 2015 May; 352(1-2):108-9. PubMed ID: 25818675
    [No Abstract]   [Full Text] [Related]  

  • 25. [Creutzfeldt-Jakob disease after treatment with human extracted growth hormone. A clinicopathological study].
    Delisle MB; Fabre N; Rochiccioli P; Doerr-Schott J; Rumeau JL; Bes A
    Rev Neurol (Paris); 1993; 149(10):524-7. PubMed ID: 8023064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human pituitary growth hormone and Creutzfeldt-Jakob disease.
    Preece M
    Horm Res; 1993; 39(3-4):95-8. PubMed ID: 8262483
    [No Abstract]   [Full Text] [Related]  

  • 27. [Uses of growth hormone].
    Rodríguez Hierro F
    Med Clin (Barc); 1986 Sep; 87(7):288-90. PubMed ID: 3531738
    [No Abstract]   [Full Text] [Related]  

  • 28. Similar genetic susceptibility in iatrogenic and sporadic Creutzfeldt-Jakob disease.
    Deslys JP; Marcé D; Dormont D
    J Gen Virol; 1994 Jan; 75 ( Pt 1)():23-7. PubMed ID: 8113733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease.
    Parchi P; Castellani R; Capellari S; Ghetti B; Young K; Chen SG; Farlow M; Dickson DW; Sima AA; Trojanowski JQ; Petersen RB; Gambetti P
    Ann Neurol; 1996 Jun; 39(6):767-78. PubMed ID: 8651649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Creutzfeldt-Jakob disease after administration of human growth hormone.
    Powell-Jackson J; Weller RO; Kennedy P; Preece MA; Whitcombe EM; Newsom-Davis J
    Lancet; 1985 Aug; 2(8449):244-6. PubMed ID: 2862420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trends in mortality from sporadic Creutzfeldt-Jakob disease in France 1992-7.
    d'Aignaux JH; Laplanche JL; Delasnerie-Lauprêtre N; Brandel JP; Peoc'h K; Salomon D; Hauw JJ; Alpérovitch A
    J Neurol Neurosurg Psychiatry; 2000 Jun; 68(6):787-9. PubMed ID: 10811709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pituitary growth hormone and Creutzfeldt-Jakob disease.
    Norrby E
    Acta Paediatr Scand Suppl; 1986; 325():116-24. PubMed ID: 3296633
    [No Abstract]   [Full Text] [Related]  

  • 33. Creutzfeldt-Jakob disease in a young adult with idiopathic hypopituitarism. Possible relation to the administration of cadaveric human growth hormone.
    Koch TK; Berg BO; De Armond SJ; Gravina RF
    N Engl J Med; 1985 Sep; 313(12):731-3. PubMed ID: 3897861
    [No Abstract]   [Full Text] [Related]  

  • 34. [Pituitary dwarfism--progress of therapy].
    Suwa S
    Nihon Rinsho; 1986 Mar; 44(3):703-10. PubMed ID: 3090312
    [No Abstract]   [Full Text] [Related]  

  • 35. [A patient with Creutzfeldt-Jakob disease following treatment with human growth hormone].
    Roos RA; Wintzen AR; Will RG; Ironside JW; van Duinen SG
    Ned Tijdschr Geneeskd; 1996 Jun; 140(22):1190-3. PubMed ID: 8692356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fatal degenerative neurologic disease in patients who received pituitary-derived human growth hormone.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1985 Jun; 34(24):359-60, 365-6. PubMed ID: 3923319
    [No Abstract]   [Full Text] [Related]  

  • 37. Creutzfeldt-Jakob disease profile in patients homozygous for the PRNP E200K mutation.
    Simon ES; Kahana E; Chapman J; Treves TA; Gabizon R; Rosenmann H; Zilber N; Korczyn AD
    Ann Neurol; 2000 Feb; 47(2):257-60. PubMed ID: 10665501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leads from the MMWR. Fatal degenerative neurologic disease in patients who received pituitary-derived human growth hormone.
    JAMA; 1985 Jul; 254(4):475, 479. PubMed ID: 3892063
    [No Abstract]   [Full Text] [Related]  

  • 39. [Iatrogenic Creutzfeld-Jakob disease induced by the administration of extracted growth hormone].
    Rev Neurol (Paris); 1993; 149(10):515-6. PubMed ID: 8023062
    [No Abstract]   [Full Text] [Related]  

  • 40. Creutzfeldt-Jakob disease in children treated with growth hormone.
    Billette de Villemeur TB; Beauvais P; Gourmelen M; Richardet JM
    Lancet; 1991 Apr; 337(8745):864-5. PubMed ID: 1672962
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.